ReviewClinical pharmacology and therapeutics2021

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Michael Z Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.